Related Experiment Video
Updated: Sep 13, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Changes in Tuberculosis Incidence and Mortality Following the End TB Strategy and the COVID-19 Pandemic in Brazil: An
Bruno Victor Barros Cabral1,2, George Jó Bezerra Sousa2,3, Thiago Santos Garcês3
1University of Brasília, Brasília, Brazil.
Background:
Tuberculosis remains a major global public health challenge, particularly in high-burden countries such as Brazil. The End TB Strategy and the COVID-19 pandemic represent key events associated with changes in tuberculosis incidence and mortality, although their temporal patterns and combined effects remain insufficiently explored.
Methods:
An ecological study using interrupted time series analysis was conducted with annual tuberculosis incidence and mortality rates in Brazil from 2001 to 2024. Prais-Winsten regression with logarithmic transformation was applied to estimate level and trend changes, considering 2015 and 2020 as interruption points within the same analytical model. Model fit was assessed using the Durbin-Watson test and adjusted R2.
Results:
In the combined two-intervention model, TB incidence showed no significant immediate change following the End TB Strategy but increased by 3.8% per year (95% CI: 2.1; 5.6; p < 0.001) between 2015 and 2020. Following the onset of the COVID-19 pandemic, incidence decreased immediately by 15.2% (95% CI: -20.6; -9.6; p < 0.001), followed by an annual increase of 3.1% (95% CI: 0.6; 5.6; p = 0.07). Mortality showed no significant immediate changes associated with either interruption but increased by 5.6% per year after 2020 (95% CI: 3.0; 8.2; p < 0.001).
Conclusion:
Changes in TB incidence and mortality were temporally associated with the selected interruption points, including an increase in incidence between 2015 and 2020 and a marked decline following the onset of the COVID-19 pandemic. However, causal attribution is limited by the ecological design, absence of a control group and the small number of observations between intervention points and after 2020.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
